Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000891020-07-000368
Filing Date
2007-12-03
Accepted
2007-12-03 17:31:16
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K v36099a1e10vkza.htm 10-K/A 57564
2 EXHIBIT 23.1 v36099a1exv23w1.htm EX-23.1 1385
3 EXHIBIT 31.1 v36099a1exv31w1.txt EX-31.1 3269
4 EXHIBIT 31.2 v36099a1exv31w2.txt EX-31.2 3347
5 EXHIBIT 32.1 v36099a1exv32w1.txt EX-32.1 1134
6 EXHIBIT 32.2 v36099a1exv32w2.txt EX-32.2 1151
8 GRAPHIC v36099a1v3609998.gif GRAPHIC 10630
9 GRAPHIC v36099a1v3609900.gif GRAPHIC 11198
10 filename10.htm CORRESP 6672
  Complete submission text file 0000891020-07-000368.txt   106412
Mailing Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814
Business Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-33393 | Film No.: 071281489
SIC: 2834 Pharmaceutical Preparations